Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders
- 1 December 2020
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 35 (3) , 539-551
Abstract
TFEB is a mammalian transcription factor that binds directly to the CLEAR consensus sequence (5′‐GTCACGTGAC‐3′) present in the regulatory regions of genes inducing autophagosome formation, autophagosome‐lysosome fusion, hydrolase enzyme expression, and lysosomal exocytosis. By modulating these activities, TFEB coordinates on‐demand control over each cell’s degradation pathway. Thus, a nuclear signaling pathway regulates cellular energy metabolism through TFEB. Our growing understanding of the role of TFEB and CLEAR in the promotion of healthy clearance together with in vitro and in vivo preclinical findings in various animal models of disease supports the conclusion that the pharmacological activation of TFEB could clear toxic proteins to treat both rare and common forms of neurodegenerative disease.Keywords
This publication has 104 references indexed in Scilit:
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net PhosphorylationCell Metabolism, 2013
- Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseEMBO Molecular Medicine, 2013
- Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiencyEMBO Molecular Medicine, 2013
- Computational classification of mitochondrial shapes reflects stress and redox stateCell Death & Disease, 2013
- A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEBThe EMBO Journal, 2012
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular ClearanceDevelopmental Cell, 2011
- Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of CancerJournal of Medicinal Chemistry, 2010
- The role of the Atg1/ULK1 complex in autophagy regulationCurrent Opinion in Cell Biology, 2010
- Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injuryExperimental Neurology, 2008
- CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failureExperimental Neurology, 2008